In October last year we had expressed the hope that data from the Men’s Eating and Living (MEAL) study would be presented at a major medical meeting this year.
The MEAL study was developed to see if changes in diet could affect the outcomes over time of men with prostate cancer on active surveillance — in terms of time to disease progression and numbers of patients going on the have definitive treatment for their prostate cancer.
We can now confirm that these data will, indeed, be presented by Parsons et al. at the upcoming annual meeting of the American Urological Association (AUA) in San Francisco.
The currently available abstract does not provide any of the results of the study. It merely notes that a total of 478 men on active surveillance were enrolled into the trial and randomized to either a telephone-based dietary counseling initiative that focused on a high-vegetable diet or a control program. On the other hand, the abstract is clear that “Final results for the primary and secodary outcomes comparing intervention to control will be presented” at the AUA meeting.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, diet, outcome, surveillance, trial |
THE "NEW" PROSTATE CANCER INFOLINK 
Leave a Reply